Title : Development of asciminib, a novel allosteric inhibitor of BCR-ABL1.

Pub. Date : 2022 Mar

PMID : 35021069






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Development of Asciminib, a Novel Allosteric Inhibitor of BCR-ABL1. asciminib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Asciminib is a promising investigational agent in development that allosterically targets BCR-ABL1 in a non-ATP-competitive manner. asciminib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens